ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

LTRN Lantern Pharma Inc

5,23
-0,23 (-4,21%)
27 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Lantern Pharma Inc LTRN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,23 -4,21% 5,23 01:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
5,55 5,42 6,04 5,50 5,46
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/04/202409:00BWLantern Pharma Launches “Webinar Wednesdays” Featuring..
22/04/202409:12BWLantern Pharma Receives Regulatory Approval to Expand..
18/03/202417:02BWLantern Pharma Reports Fourth Quarter & Fiscal Year 2023..
18/03/202408:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
15/03/202409:00BWLantern Pharma Announces Initial Patients Dosed in..
11/03/202408:30BWLantern Pharma to Report Fourth Quarter and Fiscal Year 2023..
05/03/202410:01BWLantern To Participate in H.C Wainwright & Co.’s (HCW) 1st..
04/03/202410:01BWLantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion..
15/02/202410:01BWLantern Pharma Advances Unique ADC (Antibody Drug Conjugate)..
17/01/202409:30BWStarlight Therapeutics, a Subsidiary of Lantern Pharma..
30/11/202310:00BWFDA Grants Lantern Pharma Orphan Drug Designation for Drug..
08/11/202318:01BWLantern Pharma Reports Third Quarter 2023 Financial Results..
01/11/202309:00BWLantern Pharma to Report Third Quarter 2023 Operating &..
10/10/202309:00BWLantern Pharma to Present at the ThinkEquity Conference on..
03/10/202309:00BWLantern Pharma Announces Publication in Clinical Cancer..
25/09/202309:30BWLantern Pharma Announces First Patient Dosed in the Phase 1..
18/09/202310:00BWLantern Pharma Receives IND Clearance from FDA Enabling..
31/08/202309:00BWLantern Pharma to Present Data Highlighting the Anti-Tumor..
28/08/202309:00BWLantern Pharma Expands AI Capabilities of RADR® Platform to..
14/08/202309:30BWLantern Pharma Receives Notice of US Patent Allowance for..
09/08/202317:01BWLantern Pharma Reports Second Quarter 2023 Financial Results..
02/08/202309:00BWLantern Pharma to Report Second Quarter 2023 Operating &..
17/07/202309:00BWLantern Pharma to Participate and Present at Multiple..
26/06/202309:30BWOncotarget Publishes New Data by Lantern Pharma, an AI..
12/06/202309:30BWLantern Pharma Receives FDA Clearance of IND Application for..
08/06/202310:00BWLantern Pharma Leverages AI Platform, RADR®, to Develop..
17/05/202309:00BWLantern Pharma to Present at the Lytham Partners Spring 2023..
09/05/202317:01BWLantern Pharma Reports First Quarter 2023 Financial Results..
03/05/202310:00PRNUSLantern Pharma Selects REPROCELL USA to Provide Support for..
02/05/202317:01BWLantern Pharma to Report First Quarter 2023 Operating &..
02/05/202308:30BWLantern Pharma Develops Top-Ranked AI Algorithms to Predict..

Seu Histórico Recente

Delayed Upgrade Clock